IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,834,347 | +16.6% | 459,311 | +5.5% | 0.06% | +22.9% |
| Q2 2023 | $17,863,641 | +24.5% | 435,380 | +8.5% | 0.05% | +4.3% |
| Q1 2023 | $14,343,284 | +94888.6% | 401,323 | +0.3% | 0.05% | -25.8% |
| Q4 2022 | $15,100 | -99.9% | 400,057 | +3.1% | 0.06% | -11.4% |
| Q3 2022 | $17,149,000 | -40.1% | 387,908 | -48.4% | 0.07% | +42.9% |
| Q2 2022 | $28,610,000 | +86.6% | 751,954 | +90.8% | 0.05% | +6.5% |
| Q1 2022 | $15,330,000 | +35.1% | 394,154 | +5.8% | 0.05% | +58.6% |
| Q4 2021 | $11,348,000 | -10.0% | 372,480 | -1.1% | 0.03% | -6.5% |
| Q3 2021 | $12,604,000 | -16.2% | 376,748 | -0.3% | 0.03% | -18.4% |
| Q2 2021 | $15,048,000 | +5536.0% | 377,728 | +7906.1% | 0.04% | – |
| Q4 2020 | $267,000 | -82.2% | 4,718 | -81.0% | 0.00% | -100.0% |
| Q4 2019 | $1,503,000 | -49.6% | 24,882 | -32.2% | 0.01% | -53.8% |
| Q1 2019 | $2,985,000 | +29.3% | 36,725 | -14.1% | 0.01% | +44.4% |
| Q4 2018 | $2,309,000 | +0.0% | 42,757 | -7.1% | 0.01% | +12.5% |
| Q3 2018 | $2,308,000 | -0.7% | 46,030 | -17.5% | 0.01% | +14.3% |
| Q2 2018 | $2,325,000 | -70.0% | 55,786 | -66.5% | 0.01% | +75.0% |
| Q1 2018 | $7,751,000 | +141.8% | 166,533 | +161.4% | 0.00% | -33.3% |
| Q4 2017 | $3,205,000 | -17.0% | 63,711 | -16.4% | 0.01% | -25.0% |
| Q3 2017 | $3,863,000 | -19.1% | 76,212 | -18.7% | 0.01% | -33.3% |
| Q2 2017 | $4,775,000 | +14.3% | 93,764 | -9.8% | 0.01% | +9.1% |
| Q1 2017 | $4,179,000 | +72.3% | 103,933 | +105.7% | 0.01% | +83.3% |
| Q4 2016 | $2,425,000 | +345.0% | 50,538 | +274.3% | 0.01% | +200.0% |
| Q1 2016 | $545,000 | – | 13,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |